A standard semen analysis measures concentration, motility, and morphology—but these basic numbers often miss hidden sperm issues. Discover how advanced tests like CASA, vitality staining, and DNA fragmentation analysis provide deeper insights for fertility care.

Learn how to simplify complex biotech concepts without losing accuracy. Discover strategies for science communication that resonate with investors, regulators, partners, and the public — with practical storytelling, analogies, and visuals.

Sperm health is more than fertility. Learn why male fertility testing should be part of preventive healthcare and annual men’s checkups.

Discover how translational science bridges the gap between biotech innovation and real-world healthcare impact. Learn why usability, scalability, and equity are essential for bringing fertility treatment innovations—like Aqua Fem’s AF compound—successfully from lab to life.

Explore new sperm selection methods—microfluidics, MACS, and more—reshaping ART outcomes and advancing male fertility science.

Learn how biotech startups can secure the right funding at the right time while protecting scientific integrity and mission. Aqua Fem shares insights on investor alignment and strategic capital.

Everyday habits—from diet and sleep to stress and toxins—directly affect sperm health. Learn how lifestyle changes can improve male fertility in just months.

Discover why early FDA regulatory planning is essential for biotech startups. Learn about 510(k), De Novo, PMA pathways, and how smart engagement accelerates product development and market success.

A semen analysis measures key markers of male fertility—volume, count, motility, morphology, and more. Learn what the numbers mean and why they matter.